News
Filter
-
2022 wrapped – our highlights from a pivotal year
-
LifeArc plays key role in discovery of new Alzheimer’s treatment
-
LifeArc Ventures invests in Surgery Hero, world’s first digital coaching clinic for patients
-
New toolkit launched to help repurposed medicines reach patients
-
Promising new antibody treatment for osteoporosis and multiple sclerosis
-
New £30 million translational partnership will accelerate development of new treatments for people with dementia
-
Promising new asthma medicine ready to enter early clinical trials
-
LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2
-
Living with genetic sight loss – a family story
-
Can an innovative gene therapy help people with Hunter syndrome?
-
Living with a rare but incurable liver disease
-
New study explores unique approach to treat a rare liver disease
